Related Experiment Videos
Probing interactions between viral DNA and human immunodeficiency virus type 1 integrase using dinucleotides
A Mazumder1, H Uchida, N Neamati
1Division of Basic Sciences, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, USA.
Molecular Pharmacology
|April 1, 1997
Summary
Dinucleotides show activity against retroviral integrases, including human immunodeficiency virus (HIV). Structure-activity studies reveal key modifications for potency, suggesting dinucleotides as potential antiviral leads.
Area of Science:
- Biochemistry
- Virology
- Drug Discovery
Background:
- Retroviral integrases are crucial for viral replication and are key targets for antiviral therapies.
- Understanding integrase function is vital for developing new treatments against viruses like HIV.
Purpose of the Study:
- To investigate the activity of dinucleotides against various retroviral integrases, including HIV-1, HIV-2, SIV, and FIV.
- To explore structure-activity relationships and identify key features for dinucleotide inhibition of integrase.
- To assess the potential of dinucleotides as lead compounds for antiviral drug development.
Main Methods:
- Enzymatic assays were performed to evaluate the inhibitory activity of dinucleotides against purified retroviral integrases.
- Structure-activity relationship studies involved modifying dinucleotide structures (phosphorylation, base sequence, sugar modifications) to assess their impact on potency.
- Enzyme-DNA binding assays were conducted to determine the effect of dinucleotides on integrase-DNA interactions.
Main Results:
- Micromolar concentrations of dinucleotides demonstrated inhibitory activity against HIV-1, HIV-2, SIV, and FIV integrases.
- 5'-phosphorylation significantly enhanced dinucleotide potency, while phosphodiester and sugar modifications influenced HIV-1 integrase inhibition.
- Specific base sequences (pAC, pAT, pCT) were more potent inhibitors, indicating sequence selectivity. Dinucleotides inhibited enzyme/DNA binding within their IC50 range.
Conclusions:
- Dinucleotides are effective inhibitors of retroviral integrases and can elucidate enzyme mechanisms.
- The findings highlight the potential of dinucleotides as ligands for cocrystallization and as lead structures for developing novel antiviral agents.
- While tested dinucleotides lacked direct antiviral activity, their inhibitory mechanism warrants further investigation for therapeutic applications.